Certain Compounds May Block Coronavirus From Cells, UF Health Researcher Finds
Computer simulations run by a University of Florida Health researcher have shown that three compounds appear to have the potential to block... Read More
Algernon Announces Filing of U.S. FDA Pre-Ind Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, announced that it has filed its pre-IND (Investigational New Drug) meeting request... Read More
Expert: Outbreak Transmission Dynamics
As the world grapples for answers and action on the new coronavirus outbreak, researchers who study the dynamics of infectious disease outbreaks... Read More
Will Coronavirus Disappear When Temperatures Heat Up? UF Virologist Responds
Temperatures fluctuate between hot and cold in Florida, just about as frequently as the idea that warmth might bring an end to... Read More
Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, announced that it is exploring the potential of using NP-120 (Ifenprodil) as... Read More
Coronavirus Consultant
John Lednicky, Ph.D., is a research professor, microbiologist and molecular biologist at UF’s College of Public Health and Health Professions and the Emerging Pathogens... Read More